Ethical considerations of Brain Machine Interfaces: Neuralink as a case study

Brain-Computer Interfaces (BCIs) are revolutionizing the way humans interact with machines by translating brain signals into actionable commands. While traditional BCIs use non-invasive methods like electroencephalography (EEG), Neuralink, founded by Elon Musk in 2016, has developed an invasive system aimed at achieving high-resolution, single-neuron recordings through an implant containing 1024 electrodes. Neuralink's technology holds promise for restoring mobility in patients with neurological disorders. However, the ethical implications of such invasive experiments, particularly those involving animal trials, have raised significant concerns. This paper explores the ethical issues surrounding Neuralink’s research, particularly the use of monkeys in its trials, and the associated risks to animal rights. Reports of animal suffering and deaths, including the case of a monkey known as 'Animal 15', underscore the need for greater transparency in animal experimentation and stricter ethical oversight. The paper discusses the balance between scientific innovation and the moral responsibility to minimize harm to animal subjects, advocating for improved transparency, humane treatment, and regulatory frameworks in the development of neurotechnologies. Ultimately, it calls for a responsible approach to ensure that the potential benefits of BCI technology are not achieved at the cost of animal welfare or human dignity.